Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.
Years ago, in a conversation with an endocrinologist, I mentioned there was no incentive to cure diabetes, giving the money companies were making from managing it (with testing supplies, insulin, etc.). He replied that the incumbents had no incentive to cure it, but a startup company would. Now it looks like one has—at least in one patient. Sana Biotechnology (SANA 0.00%↑) has developed a one-time treatment that could upend the entire diabetes industry.
(more…)Oh, sure, it’s kind of a bummer to see the entirety of the post-Moody’s collapse totally reverse within the first trading hour of the day. As a leader in the world of financial charting, I get to name new patterns, and I shall dub this one the Kimberly Guilfoyle Reversal.
After serious and ponderous contemplation, I have decided I vastly prefer this Monday morning to last Monday morning. Of course, the amount we’re down more modest than what we were up the prior Monday, but red is red, and all of my twenty-one short positions are looking forward to dropping at the opening bell.
